StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)

Close on Nov 17, 2026Market cap $7.07MP/E –Yield –

Exicure operating margin

Operating margin is operating income as a percentage of revenue.

Exicure's operating margin for the twelve months ending Dec 31, 2024 was -2446.4%. For fiscal 2024 it was -2446.4%, against -6.4% the year before. The highest annual figure on record is -6.4% in fiscal 2022.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-2446.4%−2440.0
FY2022Dec 31, 2022-6.4%+146.8
FY2020Dec 31, 2020-153.1%+1900.7
FY2019Dec 31, 2019-2053.8%+16436.9
FY2018Dec 31, 2018-18490.7%−18383.6
FY2017Dec 31, 2017-107.1%+1453.0
FY2016Dec 31, 2016-1560.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 2024-167.2%+134.4
Q4 FY2022Dec 31, 202285.4%+720.4
Q3 FY2022Sep 30, 2022-258.2%+17288.7
Q2 FY2022Jun 30, 2022-302.8%+916.5
Q1 FY2022Mar 31, 2022-301.6%+8598.4
Q4 FY2021Dec 31, 2021-635.0%−261.7
Q2 FY2021Jun 30, 2021-17546.8%−17456.3
Q1 FY2021Mar 31, 2021-1219.4%−1225.2
Q4 FY2020Dec 31, 2020-8900.0%−5639.0
Q3 FY2020Sep 30, 2020-373.3%+755.0
Q2 FY2020Jun 30, 2020-90.6%+1057.8
Q1 FY2020Mar 31, 20205.8%+22317.8
Q4 FY2019Dec 31, 2019-3261.0%+77872.4
Q3 FY2019Sep 30, 2019-1128.3%+9157.7
Q2 FY2019Jun 30, 2019-1148.4%+29399.0
Q1 FY2019Mar 31, 2019-22312.0%−7634.2
Q4 FY2018Dec 31, 2018-81133.3%−80975.1
Q3 FY2018Sep 30, 2018-10286.0%−9497.1
Q2 FY2018Jun 30, 2018-30547.4%–
Q1 FY2018Mar 31, 2018-14677.8%–
Q4 FY2017Dec 31, 2017-158.2%–
Q4 FY2016Dec 31, 2016-788.8%–

More Exicure figures

See a number that looks wrong?